Molecular profiling reveals that HIV-associated HL demonstrates distinct oncogenic signatures, including enhanced EBV-driven oncoprotein expression and aberrant NF-κB pathway activation, correlating with more aggressive disease phenotypes compared to HIV-negative HL cases (8, 9). The gene discussed is NFKB1; the disease is Hodgkins lymphoma.